SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-024381
Filing Date
2021-10-01
Accepted
2021-10-01 17:21:19
Documents
14
Period of Report
2021-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40802
2 ex99-1.htm EX-99.1 20703
3 ex99-2.htm EX-99.2 18498
  Complete submission text file 0001493152-21-024381.txt   260341

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxg-20210929.xsd EX-101.SCH 3028
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxg-20210929_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxg-20210929_pre.xml EX-101.PRE 22791
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3584
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 211300015
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences